Article
Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
5 Apr 2017
Abstract excerpt
Lysosomal storage disorders (LSDs) are a broad class of monogenic diseases with an overall incidence of 1:7,000 newborns, due to the defective activity of one or more lysosomal hydrolases or related proteins resulting in storage of un-degraded substrates in the lysosomes. The over 40 different known LSDs share a life-threatening nature, but they are present with extremely variable clinical manifestations,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
